Compare Mesoblast Limited (MESO) vs TeraWulf Inc (WULF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs TeraWulf Inc — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while TeraWulf Inc trades at $17.42 (market cap $8.35B). The key difference: TeraWulf Inc is far larger — about 3.8× Mesoblast Limited's market cap. Which is the better fit depends on your goals.
| MESO | WULF | |
|---|---|---|
Market Cap | $2.21B | $8.35B |
Sector | Technology | Technology |
52-Week High | $20.96 | $28.98 |
52-Week Low | $12.88 | $5.24 |
Enterprise Value | $2.21B | $10.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →
